Triasima Portfolio Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cameco
CCJ
|
+$6.04M |
| 2 |
Eli Lilly
LLY
|
+$5.71M |
| 3 |
TJX Companies
TJX
|
+$5.21M |
| 4 |
Cenovus Energy
CVE
|
+$5.08M |
| 5 |
Apple
AAPL
|
+$4.69M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RB Global
RBA
|
+$12.1M |
| 2 |
Celestica
CLS
|
+$10.8M |
| 3 |
Nutrien
NTR
|
+$8.55M |
| 4 |
Ares Management
ARES
|
+$7.79M |
| 5 |
AXON
Axon Enterprise
AXON
|
+$6.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 29% |
| 2 | Technology | 21.66% |
| 3 | Materials | 12.37% |
| 4 | Industrials | 7.35% |
| 5 | Energy | 7.11% |
Similar funds
Triasima Portfolio Management's Q4 2025 Portfolio in Review
As of Q4 2025, Triasima Portfolio Management held 171 positions worth $668M, up 0.77% from $663M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Triasima Portfolio Management withdrew a net $42.6M in Q4 2025, closing 28 positions and reducing 50 holdings. Its most notable exit was RB Global, an estimated $12.1M position sold in full.
By sector, the portfolio is most concentrated in Financials at 29% of assets, up from 27% a quarter earlier, followed by Technology and Materials.
Against the trend, Triasima Portfolio Management opened a new position in Eli Lilly worth $6.42M.
- Triasima Portfolio Management's largest Q4 2025 buy was Eli Lilly: 5,970 shares worth $6.42M.
- Triasima Portfolio Management added most to Cameco in Q4 2025, an estimated $6.04M increase.
- Triasima Portfolio Management's biggest Q4 2025 reduction was Celestica, cutting an estimated $10.8M.
- Triasima Portfolio Management fully exited RB Global in Q4 2025, selling an estimated $12.1M.
- Triasima Portfolio Management's ten largest holdings make up 32% of its $668M portfolio in Q4 2025.
- Triasima Portfolio Management opened 22 new positions and closed 28 in Q4 2025.
- Triasima Portfolio Management's portfolio value rose 0.77% quarter-over-quarter to $668M.
Based on Triasima Portfolio Management's 13F filing for Q4 2025, filed 2 Feb 2026.